The Technical AnalystExchange: SHZ Sector: Healthcare Industry: Biotechnology
Tiansheng Pharmaceutical Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.47% CNY4.32
America/New_York / 6 mai 2024 @ 02:10
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 1 373.76 mill |
| EPS: | -0.310 |
| P/E: | -13.94 |
| Earnings Date: | May 16, 2024 |
| SharesOutstanding: | 318.00 mill |
| Avg Daily Volume: | 1.395 mill |
| RATING 2024-05-06 |
|---|
| C |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Sell | |
| Return On Asset: | Sell | |
| DE: | Neutral | |
| P/E: | Strong Sell | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -13.94 | sector: PE 35.84 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.48x |
| Company: PE -13.94 | industry: PE 29.29 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
CNY-0.688 (-115.93%) CNY-5.01 |
| Date: 2024-05-05 |
| Expected Trading Range (DAY) |
|---|
|
CNY 4.20 - 4.46 ( +/- 3.05%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | CNY4.32 (0.47% ) |
| Volume | 1.004 mill |
| Avg. Vol. | 1.395 mill |
| % of Avg. Vol | 71.99 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 002872.SZ
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
002872.SZ
Tiansheng Pharmaceutical Group Co., Ltd. engages in the pharmaceutical manufacturing and circulation activities. It offers products in various categories, including respiratory, digestive, cardiovascular and cerebrovascular, pediatric, gynecological, orthopedic, tumor, hepatobiliary, blood, surgery, diabetes, and others. The company was founded in 2001 and is based in Chongqing, China.